BIBLIOGRAFÍA
1. Galie N, Torbicki A, Barst R, et al. Guidelines on diagnosis and treatment ofpulmonary arterial hypertension.The Task Force on Diagnosis and Treatmentof Pulmonary Arterial Hypertension of the European Society of Cardiology.Eur Heart J 2004;25:2243-78.
2. Barst RJ, McGoon M, Torbicki A, et al. Diagnosis and differential assessment ofpulmonary arterial hypertension. J Am CollCardiol 2004;43:40-7.
3. McGoon M, Gutterman D, Steen V, et al. Screening, early detection, and diagnosisof pulmonary arterial hypertension: ACCP evidence-based clinical practiceguidelines. Chest 2004;126:14-34.
4. Badesch DB, Abman SH, Ahearn GS, et al. Medical therapy for pulmonary arterialhypertension: ACCP evidence-based clinical practice guidelines. Chest2004;126:35-6
5. Groves BM, Badesch DB. Acute hemodynamic effects of iloprost in primary pulmonaryhipertensión.SeminRespirCrit Care Med. 1994; 15:230-7
6. Badesch D, Abman S, Simonneau G, Rubin LJ, McLaughlin V. Medical Therapy forPulmonary Arterial Hypertension: Updated ACCP Evidence-Based Clinical PracticeGuidelines. Chest. 2007;131:1917-28.
7. Consensus statement on the management of pulmonary hypertension in clinical practice inthe UK and Ireland. Thorax.2008; 63: ii1 – ii41.
8. Barbera JA, et al. Técnicas y procedimientos en hipertensión pulmonar. Manualprocedimientos SEPAR. 2007.
9. Barberà JA. Estándares asistenciales en hipertensión pulmonar. Documento de consensoelaborado por la Sociedad Española de Neumología y Cirugía Torácica (SEPAR) y laSociedad Española de Cardiología (SEC). ArchBronconeumol. 2008; 44(2):87-99